Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP1JH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,226
Award facts
- Contract value 100% obligated
- $13,225.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,225.50 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL, a biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this pharmaceutical supply requirement.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the major distributor to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen provides critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating the company's established capability to meet complex federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FP1JH?
SPE2DR26FP1JH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FP1JH worth?
The government has obligated $13,226 on SPE2DR26FP1JH.
Is contract SPE2DR26FP1JH an order under another contract?
Yes. SPE2DR26FP1JH is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1JH competed?
The extent of competition for SPE2DR26FP1JH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award